Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.
$173.78
+$0.78(+0.45%)
Content updated: 2026-11-16 17:01:39
- Yesterday's Close
- $173.00
- Today's Open
- $172.84
- Today's High
- $174.23
- Today's Low
- $170.45
- Volume
- 1.86M shares
- 52-Week Range
- $108.95-$188.20
As of 2026-11-16 17:01:39, Agilent Technologies Inc (A) was quoted at $173.78, a change of +$0.78 (+0.45%) from the previous close. The day's range was $170.45–$174.23, and the 52-week range was $108.95–$188.20.
Past 1W-4.58%Period Low $168.00Period High $183.00
Past 1M+0.22%Period Low $139.74Period High $188.20
Past 3M+21.93%Period Low $135.48Period High $188.20
About Agilent Technologies Inc (A)
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
- Ticker / Exchanges
- A / NYSE
- Industry / Sector
- Medical - Diagnostics & Research / Healthcare
- CEO
- Padraig McDonnell
- Headquarters
- Santa Clara,CA,US
- Official Website
- https://www.agilent.com
- Listing Date
- 1999-11-18
Recent Company Events
- 2026-08-26Earnings Report · ExpectedOn 2026-08-26, the 2026/Q3 earnings report is expected to be released.
Agilent Technologies Inc (A) Derivatives Trading
Agilent Technologies Inc (A) Company Financials
Valuation and Shares
- Market Cap
- --
- P/E Ratio (TTM)
- --
- P/B Ratio
- --
- Shares Outstanding
- --
- Float Shares
- --
- Dividend Yield (TTM)
- --
Latest Reported Financials
2026 Q2 FinancialsReport Release Date: 2026-05-27
Operating Revenue (Actual)
$1.83B
Same Period Last Year: +10.01%
Earnings per Share (Actual)
$1.49
Same Period Last Year: +13.74%
Financials · Actuals
| Actual Value | 2022/Annual | 2023/Annual | 2024/Annual | 2025/Annual |
|---|---|---|---|---|
| Revenue | $6.84B | $6.83B | $6.51B | $6.94B |
| Net Profit | $1.25B | $1.24B | $1.28B | $1.30B |
| Operating Cash Flow | $1.31B | $1.77B | $1.75B | $1.55B |
Learn
Gate Learn Articles
Pearl vs Bittensor, Akash, and Render: Key DifferencesPearl, Bittensor, Akash, and Render all connect GPUs to a token, but only Pearl turns matrix multiplication into the lottery that produces a block. Bittensor pays TAO for subnet work that validators score. Akash and Render sell compute: the chain that records the payment uses proof of stake, and the GPU job is not the block puzzle.2026-11-04

What is the Rising Wedge Pattern?A rising wedge pattern is a bearish chart formation: two upward-sloping trend lines converge while price prints higher highs and higher lows. Support rises faster than resistance, so the range narrows. A close below support confirms it, as a reversal after an uptrend or a continuation in a downtrend.2026-11-03

What is Polymarket? The Future of Decentralized Prediction MarketsPolymarket is a decentralized prediction market where users trade YES and NO shares on real world events. Shares settle in USDC on the Polygon blockchain and trade between 0 USD and 1 USD, so a YES price of 0.65 USD implies a 65% probability that the event occurs.2026-11-04

Blogs
Falling Oil Prices Fail to Ease Inflation Pressures: Why Are Expectations for a December Fed Rate Hike Rising?Oil prices have fallen to around $93, but core CPI has posted a 0.3% month-over-month gain for three straight months. Combined with nonfarm payrolls of 165,000 and an unemployment rate of 4.1%, CME pricing puts the probability of a 25 bps rate hike in December at roughly 92%.2026-11-16

Silver Falls Below $48: Are Weakening Demand and Capital Outflows Intensifying Market Pressure?Silver falls below $48 for the first time in a year. Metals Focus expects 2026 demand to drop 5%, with ETPs shedding 45 million ounces. This article breaks down the logic behind the simultaneous decline in both industrial and investment demand, and analyzes how interest-rate expectations flow through in sync into the crypto market.2026-11-16

Meta’s February 2027 Dividend: How Will Its New Financing Arrangements Affect META Stock?On February 15, 2027, Meta will pay a 6.5% quarterly dividend on its METAM preferred stock. Ordinary META shareholders will still receive a $0.525 quarterly cash dividend. The Class C shares issuance and $95 billion in financing will change the capital structure, diluting by about 5%–6%. The AI CapEx return—not anything else—is what will drive the valuation.2026-11-16

A FAQ
What is the current stock price of Agilent Technologies Inc (A)?
x
As of 2026-11-16 17:01 (UTC+8), the latest available quote for Agilent Technologies Inc (A) is $173.78 USD, with a change of +$0.78 USD (+0.45%) from the previous trading day's close. Current market status: Closed.
Which exchange is A listed on?
x
How has Agilent Technologies Inc stock performed over the past month?
x
What is the market cap of Agilent Technologies Inc?
x
What are Agilent Technologies Inc's latest financial results?
x
What factors may affect the stock price of Agilent Technologies Inc (A)?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.






